Oramed Issues Letter to Shareholders
– Recruiting and Dosing Patients Across Growing Number of U.S. Sites in Phase 3 Oral Insulin Trial – Clinical Advancements in NASH & Leptin – Discussions with Potential Partners Under Way – To view a video message from the CEO, click here NEW YORK, Jan. 27, 2021 /PRNewswire/ — Oramed Pharmaceuticals […]
